Correlation Between Lipocine and Mesoblast

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lipocine and Mesoblast at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Mesoblast into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and Mesoblast, you can compare the effects of market volatilities on Lipocine and Mesoblast and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Mesoblast. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Mesoblast.

Diversification Opportunities for Lipocine and Mesoblast

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Lipocine and Mesoblast is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Mesoblast in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mesoblast and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Mesoblast. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mesoblast has no effect on the direction of Lipocine i.e., Lipocine and Mesoblast go up and down completely randomly.

Pair Corralation between Lipocine and Mesoblast

Given the investment horizon of 90 days Lipocine is expected to under-perform the Mesoblast. But the stock apears to be less risky and, when comparing its historical volatility, Lipocine is 1.01 times less risky than Mesoblast. The stock trades about -0.21 of its potential returns per unit of risk. The Mesoblast is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  2,012  in Mesoblast on November 4, 2024 and sell it today you would earn a total of  2.00  from holding Mesoblast or generate 0.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy90.0%
ValuesDaily Returns

Lipocine  vs.  Mesoblast

 Performance 
       Timeline  
Lipocine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lipocine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Mesoblast 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Mesoblast are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Mesoblast displayed solid returns over the last few months and may actually be approaching a breakup point.

Lipocine and Mesoblast Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lipocine and Mesoblast

The main advantage of trading using opposite Lipocine and Mesoblast positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Mesoblast can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mesoblast will offset losses from the drop in Mesoblast's long position.
The idea behind Lipocine and Mesoblast pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Correlations
Find global opportunities by holding instruments from different markets